Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort

Published:2024-07 Issue:1 Volume:91 Page:172-175
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Peng Yanmei,Kumar Ashok V.,Gu Zhong,Kosuru Nikhila,Wampfler Jason A.,Reck dos Santos Pedro A.,Yu Nathan Y.,D'Cunha Jonathan,Ernani Vinicius,Costello Collin M.,Yang Ping

Funder

National Institute on Aging

Mayo Clinic

National Institutes of Health

Publisher

Elsevier BV

Reference5 articles.

1. 43121 Real-world analysis of skin toxicity from EGFR inhibitors: an unmet challenge;Jabbour;J Am Acad Dermatol,2023

2. Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: a literature-based meta-analysis of 24 trials;Petrelli;Lung Cancer,2012

3. Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation;Luo;J Cancer Res Clin Oncol,2022

4. Management of dermatologic complications of lung cancer therapies;Pugliese;Curr Treat Options Oncol,2015

5. Benefit of erlotinib in patients with non-small-cell lung cancer is related to smoking status, gender, skin rash and radiological response but not to histology and treatment line;Faehling;Oncology,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP